Basics Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients. IPO Date: February 22, 2000 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $311.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.91% Avg Daily Range (30 D): $0.13 | 4.76% Avg Daily Range (90 D): $0.07 | 3.75% Institutional Daily Volume Avg Daily Volume: 5.34M Avg Daily Volume (30 D): 7.62M Avg Daily Volume (90 D): 6.49M Trade Size Avg Trade Size (Sh.): 448 Avg Trade Size (Sh.) (30 D): 733 Avg Trade Size (Sh.) (90 D): 716 Institutional Trades Total Inst.Trades: 440 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.95M Avg Inst. Trade (90 D): $1.95M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.41M Avg Closing Trade (30 D): $3.15M Avg Closing Trade (90 D): $3.15M Avg Closing Volume: 79.52K     News Oct 7, 2025 @ 5:17 PM Senseonics Tumbles As Q3 Results And Split Hit Sto... Source: Lekha Gupta May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research Jan 8, 2025 @ 11:12 PM Senseonics Holdings, Inc. Announces Business Updat... Source: N/A Sep 17, 2024 @ 11:00 AM Eversense 365 Receives FDA Clearance: The Worldââ... Source: Senseonics Holdings, Inc. And Ascensia Diabetes Care Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.1 $-.02 $-.02 Diluted EPS $-.1 $-.02 $-.02 Revenue $ 25.47M $ 6.65M $ 6.26M Gross Profit $ 4.53M $ 3.12M $ 1.51M Net Income / Loss $ -68.21M $ -14.5M $ -14.26M Operating Income / Loss $ -64.93M $ -14.32M $ -13.49M Cost of Revenue $ 20.94M $ 3.53M $ 4.75M Net Cash Flow $ -3.34M $ -7.79M $ -35.29M PE Ratio     Splits Oct 20, 2025:   1:20 Nov 10, 2015:   12:1